Characterization of a synthetic peptide from the glycosaminoglycan binding site of heparin cofactor II
β Scribed by Herbert C. Whinna; Frank C. Church
- Publisher
- Springer Netherlands
- Year
- 1994
- Tongue
- English
- Weight
- 514 KB
- Volume
- 1
- Category
- Article
- ISSN
- 1573-3149
No coin nor oath required. For personal study only.
β¦ Synopsis
We characterized a synthetic peptide based on the glycosaminoglycan (GAG)-binding site of the serine proteinase inhibitor (serpin) heparin cofactor II (HCII): HCII'65-'9s, K'65DFVNASSKYEITTIHNLFRKLTHRLFRRNF'95. HCII'"5-195 negated acceleration of the HCII/thrombin inhibition reaction (IC, for the peptide shown in parentheses) by heparin (-250 nM) and dermatan sulfate (-500 nM). Circular dichroism spectra of HCII'65-'9s showed that GAGS increase the a-helical content of the peptide (percentage a-helix of the peptide/GAG complex given in parentheses): no GAG (7%) < low-molecular-weight heparin (32%) < heparin (42%) < dermatan sulfate (55%). A molecular model of HCII predicts that this region is 48% a-helix. Our results suggest: (i) HCI116s195 binds to GAGS; (ii) an a-helical conformation is preferable in the presence of GAGS; and (iii) GAGS may help stabilize a specific protein conformation in the HCII GAG-binding site, important for serpin function.
π SIMILAR VOLUMES
## Abstract Fibroblast growth factor (FGF)β2 regulates a variety of cellular functions, such as proliferation and differentiation, by binding to cell surface FGF receptors (FGFRs) in the presence of heparin proteoglycans. FGFβ2 is known as a heparinβbinding growth factor, but the localization of th
A peptide ranging from residue 229 to 240 of the D1 protein of Photosystem (PS) II was synthesized and lanthanides were used as candidates of calcium. Fluorescence and FTIR spectroscopy were used to test the conformational adaptation after lanthanide additions. Fluorescence spectroscopy showed that